Metal ion speciation in blood plasma: Gallium-67-citrate and MRI contrast agents

Journal of Nuclear Medicine

Volumn 37, Issue 2, 1996, Pages 379-386

  Jackson, Graham E ^a   Byrne, Michael J ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

computer simulation; gallium 67; Gd(III); metal speciation

Indexed keywords

GALLIUM CITRATE GA 67; PENTETATE TECHNETIUM TC 99M; SUCCIMER TC 99M;

ARTICLE; CHELATION; COMPUTER SIMULATION; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; HUMAN; IMAGE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PRIORITY JOURNAL;

CITRATES; CITRIC ACID; COMPUTER SIMULATION; CONTRAST MEDIA; GADOLINIUM; GALLIUM; GALLIUM RADIOISOTOPES; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASMS; TISSUE DISTRIBUTION;

EID: 0029966005     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Hallman PS, Perrin DD, Watt AE Computed distribution of copper(II) and zinc(II) ions among seventeen amino acids present in human blood plasma. Biochem J 1971;121:549-555.
2. Sillen LG. How have sea water and air got then present compositions? Chem Brit 1967,3.291-297.
3. Morel FM, Westall J, O'Melia C, Morgan J. Fate of trace-metals in Los-Angeles-County wastewater discharge Environ Sci Tech 1975,9:756-761.
4. Rubin M, Gohil R, Martell AE, Motekaitis R, Penhos J, Weiss P. Computer-predicted drugs for urolithiasis therapy. In Inorganic Chemistry in Biology and Medicine ACS Symp Series. 1980:381-406.
5. May P, Linder P, Williams D Computer simulation of metal ion equilibria in biofluids: models for the low-molecular-weight complex distribution of calcium(II), magneSium(II), manganese(II), iron(II), copper(II), zinc(II), and lead(II) ions in human blood plasma. J Chem Soc Dalton Trans 1977;588-595.
6. May PM. Computer applications in bioinorganic chemistry. PhD Thesis. University of St Andrews, Scotland, 1980
7. Jackson GE, Wynchank S, Woudenberg M, Gadolinium(III) complex equilibria: the implications for Gd(III) MRI contrast agents Magn Reson Med 1990, 16 57-66.
8. Martell AE, Smith RM, Motekaitis RJ NIST critical stability constants of metal complexes database. NIST Standard Reference Database 46, Gaithersburg, MD.
9. May PM, Murray K JESS, A Joint Expert Speciation System-II. The Thermodynamic Database Talanta 1991,38.1419-1426
10. Berthon GW, Hacht B, Biais M-J. May PM Copper-histidine ternary complex equilibria with glutamine, asparagine and serine The implications for computer-simulated distributions of copper(II) in blood plasma Inorg Chim Acta 1986,125.219-227.
11. Moerlem SM, Welch MJ. The chemistry of gallium and indium as related to radiopharmaceutical production Int J Nucl Med Biol 1981;8 277-287
12. Hayes RL, Hubner KF Basis for the clinical use of gallium and indium radiornuclides In: Sigel H, ed Metal Ions in Biological Systems, vol. 16, New York: Marcel Dekker, 1983;279-315.
13. Shannon RD Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenides. Acta Crystallogr 1976,A32:751-767
14. Brown PL The hydrolysis of metal ions Part 11 The ionic strength dependence of gallium(III) J Chem Soc Dalton Trans 1989,399-402
15. Harris WR, Pecoraro VL Thermodynamic binding constants for gallium transferrin Biochemistry 1983,22:292-299
16. Baldwin DA, Egan TJ An inorganic perspective of human scrum transferrin S Afr J Science 1987;83.22-31
17. Loomis LD, Raymond KN Kinetics of gallium removal from transferrin and thermodynamics of gallium-binding by sulfonated tricatechol ligands. J Coord Chem 1991,23:361-387.
18. Welch MJ, Welch TJ Solution chemistry of carrier-free indium In: Subramanian G, Rhodes BA, Cooper JF, Sodd VJ, eds. Radiopharmaceuticals. Reston. VA Society of Nuclear Medicine, 1975.73-79
19. Halpern S, Hagan P Gallium-67 citrate imaging in neoplastic and inflammatory disease Nucl Med Ann 1980,219-259
20. Taylor A, Chafetz N, Hollenbeck J, Hooser W The source of fecal gallium-clinical implications Concise communication J Nucl Med 1978,19 1214-1216
21. Nelson BM, Hayes RL, Edwards CL, Kniseley RM, Andrews GA Distribution of gallium in human tissues after intravenous administration J Nucl Med 1972;13:92-100
22. Hoffer P. Gallium: mechanisms. J Nucl Med 1980;21.282-285.
23. 67Ga localization. Nucl Med Biol 1990;17:141-149
24. Werner RE, Spencer RP, Dambro TJ, Klein BE Gallium-67 distribution in a man with a decrease in both transferrin and hepatic gallium-67 concentration J Nucl Med 1992;33:1701-1703.
25. 67Ga in normal and hypotransferremic tumor-bearing mice. J Nucl Med 1993;34-2135-2143
26. 67Ga into normal and malignant tissue. J Nucl Med 1981;22:325-332.
27. Eckelman WC. The application of receptor theory to receptor-binding and enzyme binding oncological radiopharmaceuticals. Nucl Med Biol 1994;21.759-769
28. Kaplan J, Jordan I, Sturrock A. Regulation of the transferrin-independent iron transport system in cultured cells. J Biol Chem 1991:266 2997-3004
29. Sturrock A, Alexander J, Lamb J, Craven CM, Kaplan J. Characterization of a transferrin-independent uptake system for iron in HeLa cells. J Biol Chem 1990;265 3139-3145.
30. 67Ga by tumors. Oncology 1977;34:74-77
31. Vallabhajosula SR, Harwig JF, Wolf W. Effect of pH on tumor cell uptake of radiogallium in vitro and in vivo. Eur J Nucl Med 1982;7:462-468.
32. Harris WR. Thermodynamics of gallium complexation by human lactoferrn Biochemistry 1986;25 803-808
33. 67Ga tumor-to-blood ratios and tumor imaging Eur J Nucl Med 1982;7:229-233
34. Oster ZH, Som P, Sacker DF, Atkins HL. The effects of deferoxamine mesylate on ga!lium-67 distribution in normal and abscess-bearing animals J Nucl Med 1980,21: 421-425.
35. Baker DL, Manno CS. Rapid excretion of gallium-67 isotope in an iron-overloaded patient receiving high-dose intravenous deferoxamine. Am J Hematol 1988;29:230-232
36. Hodges R Iatrogenic alterations in the biodistribution of radiotracers as a result of drug therapy: theoretical considerations. In Illadik W, Saha G, Study K, Friedman B. eds. Essentials of nuclear medicine science. Baltimore Williams and Wilkins. 1987:165-188
37. Sephton R, Martin J Modification of distribution of gallium-67 in man by administration of iron. Br J Radiol 1980;53.572-575.
38. 3 on the accumulation of gallium-67 into inflammatory and normal tissue Ann Nucl Med 1988,2.59-62.
39. 67Ga-citrate in an iron-overloaded patient with sickle cell disease. Clin Nucl Med 1993,19 157-159.
40. Moeller T. The lanthanides. In: Bailar JC, Emeleus HJ, Nyholm R. Trotman-Dickenson AF, eds., Comprehensive inorganic chemistry, vol 4. Oxford Pergamon Press, 1973:1-104
41. Lauffer RB. Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design. Chem Rev 1987;87-901-927.
42. Reuben J. Gadolinium(III) as a paramagnetic probe for proton relaxation studies of biological macromolecules: binding to bovine serum albumin Biochemistry 1971,10: 2834-2838.
43. Zak O, Aisen P Spectroscopic and thermodynamic studies on the binding of gadolimum(III) to human serum transferrn. Biochemistry 1988;27:1075-1080.
44. Harris WR, Chen Y. Difference ultraviolet spectroscopic studies on the binding of lanthanides to human serum transferrin. Inorg Chem 1992,31 5001-5006
45. Harris WR. Binding constants for neodymiun(III) and samarium(III) with human serum transferrin Inorg Chem 1986;25:2041-2045.
46. Weinmann H-J, Brash R, Press W, Weskey G Characteristics of GdDTPA complex: a potential nmr contrast agent. Am J Roentgenol 1984,142 619-624
47. Cachens W, Quay S, Rocklage S. The relationship between thermodynamics and the toxicity of gadolinium complexes Magn Reson Imaging 1990;8.467-481
48. Hattner RS, White DL. Gallium-67/stable gadolinium antagonism: MRI contrast agent markedly alters the normal biodistribution of gallium-67. J Nucl Med 1990,31:1844-1846.
49. Wiggins J, Goldstein H, Weinmann H. Gallium-67/stable gadolinium antagonism J Nucl Med 1991;32:1830-1831
50. Weinmann H-J, Press WR, Raduchel B, Platzek J, Schmitt-Willich H, Vogler H. Characteristics of Gd-DTPA and new derivatives. In: Bydder G, Felix R, Bucheler E, et al., eds Contrast media in MRI International Workshop Berlin. Bussum, The Netherlands: Medicorm Europe; 1990 19-30